BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30568356)

  • 1. Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.
    Martini AE; Jasulaitis S; Fogg LF; Uhler ML; Hirshfeld-Cytron JE
    J Hum Reprod Sci; 2018; 11(3):261-268. PubMed ID: 30568356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralipid treatment for women with reproductive failures.
    Coulam CB
    Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralipid therapy and adverse reproductive outcome: is there any evidence?
    Kumar P; Marron K; Harrity C
    Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
    Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
    Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
    Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
    Singh N; Davis AA; Kumar S; Kriplani A
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
    Check JH; Check DL
    Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells. A retrospective cohort study.
    Zhang F; Wang Z; Lian R; Diao L; Li Y; Wu Y; Yin T; Huang C
    Am J Reprod Immunol; 2023 Dec; 90(6):e13796. PubMed ID: 38009055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure.
    Alecsandru D; Garrido N; Vicario JL; Barrio A; Aparicio P; Requena A; García-Velasco JA
    Hum Reprod; 2014 Dec; 29(12):2637-43. PubMed ID: 25316448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine administration of human chorionic gonadotropin improves the live birth rates of patients with repeated implantation failure in frozen-thawed blastocyst transfer cycles by increasing the percentage of peripheral regulatory T cells.
    Liu X; Ma D; Wang W; Qu Q; Zhang N; Wang X; Fang J; Ma Z; Hao C
    Arch Gynecol Obstet; 2019 Apr; 299(4):1165-1172. PubMed ID: 30659362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
    Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
    J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the optimization of thyroid function, thrombophilia, immunity and uterine milieu treatment strategy for recurrent implantation failure and recurrent pregnancy loss.
    Kuroda K
    Reprod Med Biol; 2024; 23(1):e12561. PubMed ID: 38249354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial.
    Al-Zebeidi J; Agdi M; Lary S; Al-Obaid S; Salim G; Al-Jaroudi D
    Gynecol Endocrinol; 2020 Feb; 36(2):131-134. PubMed ID: 31220957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact of granulocyte colony-stimulating factor (G-CSF) in subcutaneous injection or intrauterine infusion and during both the fresh and frozen embryo transfer cycles on recurrent implantation failure: a systematic review and meta-analysis?
    Hou Z; Jiang F; Yang J; Liu Y; Zha H; Yang X; Bie J; Meng Y
    Reprod Biol Endocrinol; 2021 Aug; 19(1):125. PubMed ID: 34388994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
    Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
    Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta specific protein-1 in recurrent pregnancy loss and in
    Yilmaz N; Timur H; Ugurlu EN; Yilmaz S; Ozgu-Erdinc AS; Erkilinc S; Inal HA
    J Obstet Gynaecol; 2020 Aug; 40(6):843-848. PubMed ID: 31791163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralipid infusion at time of embryo transfer in women with history of recurrent implantation failure: A systematic review and meta-analysis.
    Rimmer MP; Black N; Keay S; Quenby S; Al Wattar BH
    J Obstet Gynaecol Res; 2021 Jun; 47(6):2149-2156. PubMed ID: 33754451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.